{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:40:48Z","timestamp":1758588048634,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.taap.2021.115811","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T20:27:04Z","timestamp":1638995224000},"page":"115811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Nonclinical toxicology development of a novel antibody antibiotic conjugate for treating invasive Staphylococcus Aureus infections"],"prefix":"10.1016","volume":"435","author":[{"given":"Nicola J.","family":"Stagg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Katavolos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Achilles Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Ljumanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Carrasco-Triguero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2021.115811_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e318194da65","article-title":"Endocarditis caused by Staphylococcus aureus: a reappraisal of the epidemiologic, clinical and pathologic manifestations with analysis of factors determining outcome","volume":"88","author":"Fern\u00e1ndez-Guerrero","year":"2009","journal-title":"Medicine"},{"key":"10.1016\/j.taap.2021.115811_bb0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tim.2008.11.005","article-title":"Staphylococcus aureus: new evidence for intracellular persistence","volume":"17","author":"Garzoni","year":"2009","journal-title":"Trends Microbiol."},{"issue":"2","key":"10.1016\/j.taap.2021.115811_bb0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-3782(87)90039-9","article-title":"Teratology of antituberculosis drugs","volume":"15","author":"Holdiness","year":"1987","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.taap.2021.115811_bb0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.15585\/mmwr.mm6722a2","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections among persons who inject drugs \u2014 six sites, 2005\u20132016","volume":"67","author":"Jackson","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.taap.2021.115811_bb0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature16057","article-title":"Novel antibody-antibiotic conjugate eliminates intracellular S. aureus","volume":"527","author":"Lehar","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.taap.2021.115811_bb0030","unstructured":"Multistix\u00ae10 SG, Reagent Strip for Urinalysis. Siemens Healthcare Diagnostic Inc. Terrytown, NY."},{"issue":"6","key":"10.1016\/j.taap.2021.115811_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02588-18","article-title":"A phase 1, randomized, single-ascending-dose study to investigate the safety, tolerability, and pharmacokinetics of DSTA4637S, an anti-Staphylococcus aureus Thiomab antibody-antibiotic conjugate, in healthy volunteers","volume":"63","author":"Peck","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"year":"2019","series-title":"RIFADIN\u00ae and RIFADIN\u00ae IV (rifampin), Package Insert","key":"10.1016\/j.taap.2021.115811_bb0040"},{"key":"10.1016\/j.taap.2021.115811_bb0045","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of mortality in Staphylococcus aureus bacteremia","volume":"25","author":"van Hal","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"year":"2017","series-title":"VANCOCIN\u00ae (Vancomycin Hydrochloride), Package Insert","key":"10.1016\/j.taap.2021.115811_bb0050"},{"issue":"8","key":"10.1016\/j.taap.2021.115811_bb0055","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1080\/19420862.2016.1229722","article-title":"Pharmacokinetics and pharmacodynamics of DSTA4637A: a novel THIOMABTM antibody antibiotic conjugate against Staphylococcus aureus in mice","volume":"8","author":"Zhou","year":"2016","journal-title":"mAbs"},{"issue":"10","key":"10.1016\/j.taap.2021.115811_bb0060","first-page":"1","article-title":"Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: longitudinal pharmacodynamic assessment by bioluminescence imaging","volume":"14","author":"Zhou","year":"2019","journal-title":"Plus One"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21004154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21004154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:56:33Z","timestamp":1758574593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X21004154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":12,"alternative-id":["S0041008X21004154"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115811","relation":{},"ISSN":["0041-008X"],"issn-type":[{"type":"print","value":"0041-008X"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonclinical toxicology development of a novel antibody antibiotic conjugate for treating invasive Staphylococcus Aureus infections","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115811"}}